Intracellular delivery of nano‐drug‐carriers (NDC) to specific cells, diseased regions, or
solid tumors has entered the era of precision medicine that requires systematic knowledge …

Parkinson's disease (PD) and Alzheimer's disease (AD) are neurodegenerative disorders
caused by the interaction of genetic, environmental, and familial factors. These diseases …

In vitro models of the human blood–brain barrier (BBB) are increasingly used to develop
therapeutics that can cross the BBB for treating diseases of the central nervous system. Here …

Tridimensional cultures of human induced pluripotent cells (iPSCs) experimentally directed
to neural differentiation, termed “brain organoids” are now employed as an in vitro assay that …

Neurological disorders including neurodegenerative diseases, brain tumors, and stroke are
the second leading cause of death and the greatest cause of disability worldwide. However …

Tissue barriers in a body, well known as tissue-to-tissue interfaces represented by
endothelium of the blood vessels or epithelium of organs, are essential for maintaining …

The increasing prevalence of neurological and psychiatric diseases, such as Alzheimer
disease and schizophrenia, necessitates the development of new research tools to …

Bioassembly encompasses various techniques such as bioprinting, microfluidics, organoids,
and self-assembly, enabling advances in tissue engineering and regenerative medicine …

Neurological disorders including neurodegenerative diseases, brain tumors, and stroke are
the second leading cause of death and the greatest cause of disability worldwide. However …